首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1297779

全球骨科植入物市場 - 2023-2030年

Global Orthopedic Implants Market - 2023-2030

出版日期: 2023年06月15日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球骨科植入物市場規模在2022年達到447億美元，預計到2030年將出現有利可圖的成長，達到716億美元。在2023-2030年的預測期內，該市場的年復合成長率為6.2%。

骨科植入物是由各種生物材料開發的，在毒性、細胞毒性和敏化方面進行了生物評估。材料強化技術，如塗層、合金化和抗氧化，被用來提高植入物材料的耐腐蝕性和惰性。

植入物與骨組織的整合目前正受到關注，以提高植入物在治療骨損傷方面的生物、臨床甚至生物力學效益。

市場動態

肌肉骨骼疾病的發病率不斷增加

骨折、骨關節炎、骨質疏鬆症等肌肉骨骼疾病的發病率不斷上升，是推動骨科植入物市場佔有率的主要因素。由於人口老齡化、久坐不動的生活方式和慢性病的增加，肌肉骨骼疾病在全球範圍內變得越來越普遍。這些疾病往往需要手術干涉和骨科植入物進行關節置換、骨折固定和脊柱穩定。

隨著肌肉骨骼疾病的發病率持續上升，人們對骨科植入物的需求不斷增加，以恢復活動能力，減輕疼痛，並改善受影響者的生活品質。這種對骨科植入物需求的增加，促進了市場佔有率的成長。

例如，2023年4月，Globus Medical是一家開發和商業化醫療保健解決方案的醫療器械公司，其使命是改善肌肉骨骼疾病患者的生活品質。 Globus致力於醫療器械的創新，並為醫院、非住院手術中心和醫生提供卓越的服務，以推進病人護理和提高效率。

骨科植入物的高成本

在預測期內，骨科植入物的高成本阻礙了市場的佔有率。骨科植入物的高成本可能使許多病人無法負擔，特別是在醫療資源有限或保險範圍不足的地區。這可能導致延遲或推遲手術或考慮其他治療方案。

在發展中國家，醫療基礎設施和資源可能有限，骨科植入物的高成本可能是一個重大障礙。它可能會阻礙先進的植入技術的採用，並限制人們獲得高品質的骨科護理。

COVID-19影響分析

COVID-19大流行病對骨科植入物市場產生了重大影響。在大流行期間，人們明顯轉向遠程醫療和遠程護理服務，以盡量減少親臨現場，降低病毒傳播的風險。然而，骨科手術通常需要親自評估和操作，限制了遠程醫療在這一領域的應用範圍。

大流行病造成的經濟衰退和COVID-19應對措施的醫療支出增加使醫療預算緊張。醫院和醫療機構面臨財務挑戰，可能導致對骨科植入物和相關程序的投資減少。

俄羅斯-烏克蘭衝突分析

俄烏衝突對全球骨科植入物市場產生了重大影響。衝突導致了政治不穩定，造成了不確定性，擾亂了貿易關係。一些國家的政治緊張局勢和製裁會影響骨科植入物的進出口，有可能導致供應鏈的中斷和市場的不確定性。

衝突可能限制醫療機構獲得骨科植入物技術的最新進展。國際合作、研究和獲得尖端植入技術的機會可能會受到阻礙，可能會減緩新植入技術的創新和採用。

Market Overview

The Global Orthopaedic Implants market size reached US$ 44.7 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 71.6 billion by 2030. The market is exhibiting at a CAGR of 6.2% during the forecast period 2023-2030.

Orthopedic implants have been developed from various biomaterials biologically evaluated in aspects of toxicity, cytotoxicity, and sensitization. Material enhancement techniques such as coating, alloying, and antioxidation are used to increase the corrosion resistance and inertness of the implant materials.

Integration of the implant into the bone tissue is currently under interest to enhance the biological, clinical, and even biomechanical benefits of the implants in the treatment of bone injuries.

Market Dynamics

Increasing prevalence of musculoskeletal disorders

The increasing prevalence of musculoskeletal disorders such as bone fractures, osteoarthritis, and osteoporosis is the major factor driving the orthopedic implants market share. Musculoskeletal disorders are becoming more prevalent globally due to aging populations, sedentary lifestyles, and increased chronic conditions. These disorders often require surgical intervention and orthopedic implants for joint replacements, fracture fixation, and spinal stabilization.

As the prevalence of musculoskeletal disorders continues to rise, there is a growing demand for orthopedic implants to restore mobility, alleviate pain, and improve the quality of life for affected individuals. This increased demand for orthopedic implants contributes to the growth of the market share.

For instance, in April 2023, Globus Medical, a medical device company that develops and commercializes healthcare solutions and whose mission is to improve the quality of life of patients with musculoskeletal disorders. Globus is committed to medical device innovation and delivering exceptional service to hospitals, ambulatory surgery centers, and physicians to advance patient care and improve efficiency.

High cost of the orthopedic implants

The high cost of the orthopedic implants hamper the market share during the forecast period. The high cost of orthopedic implants can make them unaffordable for many patients, particularly in regions with limited healthcare resources or inadequate insurance coverage. This can result in delayed or deferred surgeries or alternative treatment options being considered.

In developing countries, where healthcare infrastructure and resources may be limited, the high cost of orthopedic implants can be a significant barrier. It can hinder the adoption of advanced implant technologies and restrict access to quality orthopedic care.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the orthopedic implants market. During the pandemic, there was a significant shift towards telemedicine and remote care delivery to minimize in-person visits and reduce the risk of virus transmission. However, orthopedic surgeries typically require in-person evaluations and procedures, limiting the scope of telemedicine in this field.

The economic downturn caused by the pandemic and increased healthcare spending on COVID-19 response strained healthcare budgets. Hospitals and healthcare facilities faced financial challenges, potentially leading to reduced investments in orthopedic implants and related procedures.

Russia-Ukraine Conflict Analysis

The Russia-Ukraine conflict has had a significant impact on the orthopaedic implants market globally. The conflict has resulted in political instability, creating uncertainties and disrupting trade relationships. Political tensions and sanctions imposed by some countries can affect the import and export of orthopedic implants, potentially leading to supply chain disruptions and market uncertainties.

The conflict may limit access to the latest advancements in orthopedic implant technologies for healthcare providers. International collaborations, research, and access to cutting-edge implant technologies may be hindered, potentially slowing innovation and adoption of new implant technologies.

Segment Analysis

The Global Orthopaedic Implants Market is segmented based on product, material, end-user, and region.

Based on the product, reconstructive joint replacements are expected to dominate the market share.

Based on the product, reconstructive joint replacements, such as hip and knee implants, are expected to dominate the market share in the Orthopedic Implants market. Reconstructive joint replacements are surgical procedures that involve replacing a damaged or diseased joint with an artificial implant.

They can alleviate pain, enhance joint function, and improve the overall quality of life for individuals suffering from joint-related issues. The positive patient experiences and long-term benefits have contributed to the dominance of reconstructive joints. For instance, in May 2023, Zimmer Biomet Holdings, a global medical technology leader, announced that it had reached a definitive agreement to acquire OSSIS.

This privately-held medical device company specializes in personalized 3D printed implants and complex hip replacements, including second-time hip replacements and replacements involving bone tumors and trauma. The reconstructive joint replacements segment accounted for the highest market stake, accounting for approximately 32.9% of the orthopedic implants market in 2022.

Geographical Analysis

North America holds the largest market share during the forecast period

North America is estimated to hold around 38.7% of the total market share throughout the forecast period, owing to the development of novel devices and favorable government initiatives. North America is known for its strong research and development capabilities in the medical device industry.

The region has many leading orthopedic implant manufacturers and research institutions continually striving to develop and innovate novel devices. Developing advanced implant technologies, such as 3D printing, bioresorbable, and smart implants, has helped drive market growth in North America.

Government initiatives play a crucial role in shaping the orthopedic implant market. In North America, government bodies and regulatory agencies provide support and create a conducive environment for developing, approving, and adopting orthopedic implants. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) in the United States, ensure safety and efficacy standards while facilitating market entry for innovative devices.

Competitive Landscape

The major global players in the market include: Johnson & Johnson, Zimmer Biomet, Stryker Corporation, Medtronic Plc, Smith and Nephew Plc, Wright Medical Group N.V., CONMED Corporation, Arthrex Inc., DJO Global, and Globus Medical.

Why Purchase the Report?

To visualize the Global Orthopedic Implants Market segmentation based on product, material, end-user, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous orthopedic implants market-level data points with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The Global Orthopedic Implants Market Report Would Provide Approximately 54 Tables, 46 Figures And 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Material
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing prevalence of musculoskeletal disorders
- 4.1.2. Restraints
  - 4.1.2.1. High cost of the orthopedic implants
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Before COVID-19 Scenario
- 6.1.2. Present COVID-19 Scenario
- 6.1.3. Post COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer's Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Reconstructive joint replacements*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Spinal implants
7.4. Dental implants
7.5. Orthobiologics
7.6. Craniomaxillofacial
7.7. Others

8. By Material

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 8.1.2. Market Attractiveness Index, By Material
8.2. Ceramics*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Polymeric materials
8.4. Natural materials

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Orthopaedic Clinics
9.4. Homecare
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. The U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. The UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Johnson & Johnson*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Zimmer Biomet
12.3. Stryker Corporation
12.4. Medtronic Plc
12.5. Smith and Nephew Plc
12.6. Wright Medical Group N.V.
12.7. CONMED Corporation
12.8. Arthrex Inc.
12.9. DJO Global
12.10. Globus Medical

LIST NOT EXHAUSTIVE